ALK POSITIVE LUNG CANCER (UK)
We provide a support network in the UK for patients with ALK-positive lung cancer and their families. We provide advice and information so that patients can be empowered to have meaningful conversations with their healthcare professionals. We advocate on their behalf at a national level so that patients receive a high level of care wherever they live in the UK
Objects
TO RELIEVE SICKNESS AND TO PRESERVE AND PROTECT GOOD HEALTH OF UK ANAPLASTIC LYMPHOMA KINASE (ALK) POSITIVE LUNG CANCER PATIENTS BY:-A. PROVIDING AN INFORMATION RESOURCE, IN PARTICULAR ACCESS TO INFORMATION ABOUT LATEST DEVELOPMENTS AND CLINICAL TRIALS;B. IDENTIFYING AND LOCATING UK ALK PATIENTS AND OFFERING SUPPORT AND GUIDANCE ON THE LOCATION OF UK ALK SPECIALISTS AND SERVICES;C. LIAISING WITH AND INFLUENCING DECISION MAKERS, E.G. NICE, NHS, DVLA;D. RAISING AWARENESS OF ALK LUNG CANCER, PARTICULARLY AMONGST THE MEDICAL PROFESSION SO AS TO PROMOTE THE BEST TREATMENT FOR PATIENTS;E. LIAISING WITH RELEVANT ORGANISATIONS, IN PARTICULAR ROY CASTLE LUNG CANCER FOUNDATION AND THE PHARMACEUTICAL INDUSTRY;F. RAISING FUNDS FOR THE ABOVE PURPOSES.
Financial health, per its FY2024 accounts
The accounts state that the charity held unrestricted reserves of £177,023 at the end of the year, representing a year-on-year increase of £68,000 driven by increased fundraising and donations. The trustees note uncertainty regarding future conference funding and the need to employ a part-time CEO, indicating an expectation to draw on these balances in future years. The charity describes itself as risk averse, ensuring sufficient funds are held before committing to expenditure.
What the accounts disclose
“With uncertainty about funding of future conferences and the need to employ a part-time CEO, it is expected that we will draw on balances in future years.”
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Internal charity financial controls policy and procedures
- Investing charity funds policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
- Debra Louise Montaguechair
- Andrew Thomson McKay
- Geoffrey Paul Otterman
- Graham Herbert Lavender
- Rachel Rowan
- Traceydawn White
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £220k | £153k |
| 31/12/2023 | £183k | £202k |
| 31/12/2022 | £131k | £115k |
| 31/12/2021 | £164k | £108k |
| 31/12/2020 | £56k | £24k |
Common questions
Is ALK POSITIVE LUNG CANCER (UK) financially healthy?
Per its FY2024 accounts: The accounts state that the charity held unrestricted reserves of £177,023 at the end of the year, representing a year-on-year increase of £68,000 driven by increased fundraising and donations. The trustees note uncertainty regarding future conference funding and the need to employ a part-time CEO, indicating an expectation to draw on these balances in future years. The charity describes itself as risk averse, ensuring sufficient funds are held before committing to expenditure. Its FY2024 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £15k |
| THE IAN ASKEW CHARITABLE TRUST | 2 | £5k |
| DORIS FIELD CHARITABLE TRUST | 2 | £3k |
| THE OAKDALE TRUST | 2 | £2k |
| GUY'S AND ST THOMAS' FOUNDATION | 1 | £872k |
| THE FIDELITY UK FOUNDATION | 1 | £419k |
| BUPA FOUNDATION | 1 | £210k |
| THE MICHAEL COWAN FOUNDATION | 1 | £150k |
Charities like this
- JIACAI FOUNDATION
- Asthma and Lung UK
- BRITISH THORACIC ONCOLOGY GROUP
- ASSOCIATION OF CANCER PHYSICIANS
- CANCER SUPPORT UK (CSUK)
- ROY CASTLE LUNG CANCER FOUNDATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ALK POSITIVE LUNG CANCER (UK) | £220k | — | 0 | unclear | — | noted |
| JIACAI FOUNDATION | £210k | — | 0 | below | 17.5% | no doubt |
| Asthma and Lung UK | £16.1m | — | — | unclear | — | no doubt |
| BRITISH THORACIC ONCOLOGY GROUP | £1.7m | — | 0 | unclear | — | no doubt |
| ASSOCIATION OF CANCER PHYSICIANS | £101k | — | 0 | unclear | — | no doubt |
| CANCER SUPPORT UK (CSUK) | £599k | — | — | unclear | — | no doubt |